Business Description
Syntara Ltd
NAICS : 325412
SIC : 2834
ISIN : AU0000312480
Description
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring, and neuroinflammation.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 15.11 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -21.14 | |||||
| Beneish M-Score | -5.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.6 | |||||
| 3-Year EBITDA Growth Rate | 32.7 | |||||
| 3-Year EPS without NRI Growth Rate | 21.4 | |||||
| 3-Year FCF Growth Rate | 32 | |||||
| 3-Year Book Growth Rate | 48.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -16.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.79 | |||||
| Quick Ratio | 1.79 | |||||
| Cash Ratio | 0.65 | |||||
| Days Inventory | 268.29 | |||||
| Days Sales Outstanding | 109.18 | |||||
| Days Payable | 148.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.1 | |||||
| Shareholder Yield % | -9.76 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.06 | |||||
| Operating Margin % | -438.65 | |||||
| Net Margin % | -197.05 | |||||
| ROE % | -221.5 | |||||
| ROA % | -94.32 | |||||
| ROIC % | -332.95 | |||||
| ROC (Joel Greenblatt) % | -1484.9 | |||||
| ROCE % | -146.07 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6.22 | |||||
| PB Ratio | 14 | |||||
| EV-to-EBIT | -5.54 | |||||
| EV-to-EBITDA | -5.64 | |||||
| EV-to-FCF | -5.08 | |||||
| Price-to-Median-PS-Value | 0.87 | |||||
| Earnings Yield (Greenblatt) % | -18.05 | |||||
| FCF Yield % | -18.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PMXSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syntara Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.005 | ||
| Beta | 0 | ||
| Volatility % | 16.13 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0.026 | ||
| 12-1 Month Momentum % | -16.13 | ||
| 52-Week Range ($) | 0.026 - 0.026 | ||
| Shares Outstanding (Mil) | 1,193.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Syntara Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Syntara Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Syntara Ltd Frequently Asked Questions
What is Syntara Ltd(PMXSF)'s stock price today?
The current price of PMXSF is $0.03. The 52 week high of PMXSF is $0.03 and 52 week low is $0.03.
When is next earnings date of Syntara Ltd(PMXSF)?
The next earnings date of Syntara Ltd(PMXSF) is .
Does Syntara Ltd(PMXSF) pay dividends? If so, how much?
Syntara Ltd(PMXSF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers